ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $419K invested in Entero Therapeutics in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$257K
2
+$43K
3
+$13.4K
4
UBS Group
UBS Group
Switzerland
+$10.7K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$9K

Top Sellers

1
-$19K
2
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$257K
2
$72.3K
3
$43K
4
$13.4K
5
$12.6K
6
$9K
7
$6K
8
$2.44K
9
$2K
10
$197
11
$149
12
$65
13
$29
14
$21
15
$7
16
$7
17
$3
18
–
19
–